GENFLEET will present preclinical research data for three products at the AACR annual meeting
GENFLEET-B (02595.HK) announced that the company will present preclinical research data for three products: GFH276 (non-degradable molecular glue), GFS784 (a novel conjugate drug that connects functional antibodies and mechanism synergistic targeted drug payloads), and GFH603 (molecular glue covalent allosteric activator) at the poster session of the 2026 AACR Annual Meeting.
This year's AACR Annual Meeting will be held in San Diego, USA, from April 17 to 22, and the company's poster presentations will be displayed on April 19 and 21
Source: AASTOCKS The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments